Brain & Behavior Research Foundation presents:

Widely Prescribed Stimulants and the Risk of Psychosis in Young People with ADHD

Tuesday, July 14, 2020 | 2:00 pm EDT


The prescription use of stimulants such as Ritalin and Adderall (methylphenidate and amphetamine, respectively) for the treatment of ADHD has been increasing. In 2007, the FDA mandated changes to drug labels for stimulants, based on findings about increased risk for psychosis. We studied whether the risk of psychosis in patients with ADHD differs among various stimulant types and found that patients prescribed amphetamine were at a higher risk of new psychosis requiring treatment with antipsychotic medicines than patients who had been prescribed methylphenidate.


Lauren Moran, M.D.

Harvard Medical School / McLean Hospital

2013 Young Investigator Grant

Host: Jeffrey Borenstein, M.D.


Jeffrey Borenstein, M.D.

President & CEO, Brain & Behavior Research Foundation
Host, Healthy Minds Television

Each month, BBRF hosts a complimentary Meet the Scientist Webinar. Join us online and learn about the latest research from international experts in the field of brain and behavior research. Complete webinar schedule >

Brain & Behavior Research Foundation
100% of every dollar donated to BBRF for research goes to research
Charity Watch      GuideStar      Better Business Bureau
Facebook   Twitter      YouTube   LinkedIn

Copyright © 2020 Brain & Behavior Research Foundation, All rights reserved.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.